Pharma Sources Insight January 2021 focuses on the following topics:
PHARMA IN CHINA
- Biosimilars 2020: Low Approvals, but Significant Advances
- Chinese-produced Anticancer Drugs Granted Designations by the FDA in 2020
- A Brief Preview of 2021 in the Pharmaceutical Industry
COVID-19
- A Brief Overview of COVID-19 Pandemic in 2020
- Chinese Vaccines Going Global amid Receipt of the COVID-19 Vaccines Worldwide
- Notable Vaccines Against COVID-19 Making Promising Progress
Brand Story











(All Rights Reserved)